Skip to main content

Eileen Maziarz

Associate Professor of Medicine
Medicine, Infectious Diseases
DUMC 102359, 315 Trent Drive, Hanes House 153, Durham, NC 27710
DUMC 102359, 315 Trent Drive, Hanes House 153, Durham, NC 27710

Selected Grants


Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients (U01)

Clinical TrialCo Investigator · Awarded by Vanderbilt University Medical Center · 2022 - 2025

VTEU 14-0053 Task C Option 2 Protocol Implementation

ResearchInvestigator · Awarded by National Institutes of Health · 2018 - 2024

Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)

Inst. Training Prgm or CMEAssociate Director · Awarded by National Institutes of Health · 2018 - 2024

VTEU 14-0053 Task C Option 4 Protocol Implementation

ResearchInvestigator · Awarded by National Institutes of Health · 2019 - 2023

VTEU 14-0053 Task C Option 3 Protocol Implementation

ResearchInvestigator · Awarded by National Institutes of Health · 2015 - 2023

VTEU 14-0053 Task Area A Project Logistics and Site Activation

ResearchInvestigator · Awarded by National Institutes of Health · 2018 - 2019

VTEU: Task Area C: Protocol Implementation - Option 2 Protocol #14-0053

ResearchInvestigator · Awarded by National Institutes of Health · 2015 - 2019

Global Survey of Bloodstream Infections in High Risk Neutropenic Cancer Patients

ResearchPrincipal Investigator · Awarded by University of Nebraska Medical Center · 2016 - 2018

VTEU: Base -Task Area A: Project Logistics and Site Activation Protocol #14-0053

Clinical TrialInvestigator · Awarded by National Institutes of Health · 2015 - 2017

VTEU: Option 1-Task Area B: Protocol Development Protocol #14-0053

Clinical TrialInvestigator · Awarded by National Institutes of Health · 2015 - 2016

External Relationships


  • Advarra
  • Karius, Inc.

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.